Logo image of NK.PA

IMERYS SA (NK.PA) Stock Fundamental Analysis

EPA:NK - Euronext Paris - Matif - FR0000120859 - Common Stock - Currency: EUR

28.88  -0.1 (-0.35%)

Fundamental Rating

3

NK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. Both the profitability and financial health of NK have multiple concerns. NK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NK had negative earnings in the past year.
In the past year NK had a positive cash flow from operations.
Of the past 5 years NK 4 years were profitable.
In the past 5 years NK always reported a positive cash flow from operatings.
NK.PA Yearly Net Income VS EBIT VS OCF VS FCFNK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a Return On Assets value of -1.42%, NK is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
NK has a worse Return On Equity (-2.90%) than 76.92% of its industry peers.
NK has a worse Return On Invested Capital (3.55%) than 76.92% of its industry peers.
NK had an Average Return On Invested Capital over the past 3 years of 4.04%. This is below the industry average of 7.83%.
Industry RankSector Rank
ROA -1.42%
ROE -2.9%
ROIC 3.55%
ROA(3y)0.77%
ROA(5y)1.2%
ROE(3y)1.95%
ROE(5y)2.88%
ROIC(3y)4.04%
ROIC(5y)4.11%
NK.PA Yearly ROA, ROE, ROICNK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

NK has a Operating Margin of 7.70%. This is in the lower half of the industry: NK underperforms 69.23% of its industry peers.
NK's Operating Margin has declined in the last couple of years.
NK's Gross Margin of 66.83% is amongst the best of the industry. NK outperforms 92.31% of its industry peers.
NK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.7%
PM (TTM) N/A
GM 66.83%
OM growth 3Y-6.92%
OM growth 5Y-1.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.13%
GM growth 5Y2.94%
NK.PA Yearly Profit, Operating, Gross MarginsNK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NK is destroying value.
NK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NK has more shares outstanding
NK has a better debt/assets ratio than last year.
NK.PA Yearly Shares OutstandingNK.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NK.PA Yearly Total Debt VS Total AssetsNK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.84 indicates that NK is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.84, NK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Debt to FCF ratio of NK is 19.15, which is on the high side as it means it would take NK, 19.15 years of fcf income to pay off all of its debts.
NK has a worse Debt to FCF ratio (19.15) than 69.23% of its industry peers.
NK has a Debt/Equity ratio of 0.56. This is a neutral value indicating NK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, NK is doing worse than 84.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.15
Altman-Z 1.84
ROIC/WACC0.6
WACC5.96%
NK.PA Yearly LT Debt VS Equity VS FCFNK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NK has a Current Ratio of 1.99. This is a normal value and indicates that NK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NK (1.99) is better than 76.92% of its industry peers.
NK has a Quick Ratio of 1.25. This is a normal value and indicates that NK is financially healthy and should not expect problems in meeting its short term obligations.
NK has a Quick ratio of 1.25. This is in the better half of the industry: NK outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.25
NK.PA Yearly Current Assets VS Current LiabilitesNK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

The earnings per share for NK have decreased strongly by -296.20% in the last year.
NK shows a decrease in Revenue. In the last year, the revenue decreased by -4.99%.
The Revenue has been decreasing by -3.71% on average over the past years.
EPS 1Y (TTM)-296.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153.07%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-0.55%
Revenue growth 5Y-3.71%
Sales Q2Q%-6.94%

3.2 Future

NK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.99% yearly.
NK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y-4.67%
EPS Next 2Y1.53%
EPS Next 3Y7.99%
EPS Next 5YN/A
Revenue Next Year-0.54%
Revenue Next 2Y1.68%
Revenue Next 3Y3.76%
Revenue Next 5Y4.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NK.PA Yearly Revenue VS EstimatesNK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
NK.PA Yearly EPS VS EstimatesNK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 10.11, the valuation of NK can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NK indicates a somewhat cheap valuation: NK is cheaper than 69.23% of the companies listed in the same industry.
NK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.25.
Industry RankSector Rank
PE N/A
Fwd PE 10.11
NK.PA Price Earnings VS Forward Price EarningsNK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

NK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NK is cheaper than 69.23% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NK is valued a bit more expensive than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.58
EV/EBITDA 6.46
NK.PA Per share dataNK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.53%
EPS Next 3Y7.99%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.00%, NK is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.43, NK pays a better dividend. On top of this NK pays more dividend than 92.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, NK pays a better dividend.
Industry RankSector Rank
Dividend Yield 5%

5.2 History

The dividend of NK decreases each year by -8.90%.
Dividend Growth(5Y)-8.9%
Div Incr Years1
Div Non Decr Years1
NK.PA Yearly Dividends per shareNK.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of NK are negative and hence is the payout ratio. NK will probably not be able to sustain this dividend level.
DP-121.68%
EPS Next 2Y1.53%
EPS Next 3Y7.99%
NK.PA Yearly Income VS Free CF VS DividendNK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

IMERYS SA

EPA:NK (6/6/2025, 7:00:00 PM)

28.88

-0.1 (-0.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-28 2025-04-28
Earnings (Next)07-29 2025-07-29
Inst Owners68.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.45B
Analysts80
Price Target38.76 (34.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5%
Yearly Dividend1.37
Dividend Growth(5Y)-8.9%
DP-121.68%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.11
P/S 0.68
P/FCF 24.58
P/OCF 5.15
P/B 0.75
P/tB 2.36
EV/EBITDA 6.46
EPS(TTM)-1.15
EYN/A
EPS(NY)2.86
Fwd EY9.89%
FCF(TTM)1.17
FCFY4.07%
OCF(TTM)5.6
OCFY19.4%
SpS42.44
BVpS38.62
TBVpS12.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.42%
ROE -2.9%
ROCE 4.86%
ROIC 3.55%
ROICexc 3.99%
ROICexgc 7.12%
OM 7.7%
PM (TTM) N/A
GM 66.83%
FCFM 2.77%
ROA(3y)0.77%
ROA(5y)1.2%
ROE(3y)1.95%
ROE(5y)2.88%
ROIC(3y)4.04%
ROIC(5y)4.11%
ROICexc(3y)4.71%
ROICexc(5y)4.71%
ROICexgc(3y)8.34%
ROICexgc(5y)8.54%
ROCE(3y)5.51%
ROCE(5y)5.6%
ROICexcg growth 3Y-6.21%
ROICexcg growth 5Y-5.27%
ROICexc growth 3Y-5.53%
ROICexc growth 5Y-4.67%
OM growth 3Y-6.92%
OM growth 5Y-1.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.13%
GM growth 5Y2.94%
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.15
Debt/EBITDA 3.23
Cap/Depr 128.58%
Cap/Sales 10.43%
Interest Coverage 4.58
Cash Conversion 83.49%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.25
Altman-Z 1.84
F-Score6
WACC5.96%
ROIC/WACC0.6
Cap/Depr(3y)131.01%
Cap/Depr(5y)116.34%
Cap/Sales(3y)10.27%
Cap/Sales(5y)9.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-296.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153.07%
EPS Next Y-4.67%
EPS Next 2Y1.53%
EPS Next 3Y7.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-0.55%
Revenue growth 5Y-3.71%
Sales Q2Q%-6.94%
Revenue Next Year-0.54%
Revenue Next 2Y1.68%
Revenue Next 3Y3.76%
Revenue Next 5Y4.9%
EBIT growth 1Y-0.64%
EBIT growth 3Y-7.43%
EBIT growth 5Y-5.49%
EBIT Next Year116.15%
EBIT Next 3Y32.76%
EBIT Next 5YN/A
FCF growth 1Y-73.56%
FCF growth 3Y-17.98%
FCF growth 5Y-13.24%
OCF growth 1Y-39.53%
OCF growth 3Y-4.3%
OCF growth 5Y-1.59%